NXP-3P2401262026-13 — Nexaph Retatrutide
Independently TestedNexaph | Retatrutide, last activity 4 hours ago
6 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Share in Telegram →Look up lots from Telegram: @PepBatchBot→
Test Results
Result
Heavy metals analysis. — As: not detected. Cd: not detected. Pb: not detected. Hg: not detected. Vacuum check results: strong vacuum.
Result
Fentanyl presence analysis. — Fentanyl presence. Negative.
Result
LCMS screening. — LCMS screening LCMS analysis identified the presence of mannitol, retatrutide, and degradation products. LCMS spectra are attached. No significant contamination detected.
Dosing with this lot
The label says 24 mg. Janoshik weighed 26.2 mg — 9% more than the label. Your dose depends on what is really in the vial, so the calculator uses the measured amount.
Draw
18 units
on a U-100 insulin syringe, for 2.4 mg
Going by the label you would draw 20 units — which from this vial is actually 2.62 mg, not 2.4 mg.
- The vial holds dry powder: 26.2 mg of Retatrutide, as weighed.
- Water spreads that powder evenly through the liquid: 26.2 mg ÷ 2 ml = 13.1 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 131 mcg.
- Your dose divided by that: 2.4 mg ÷ 131 mcg = 18 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
2 community mentions, no summary yet
same lot series
1 community mention, no summary yet
Tirzepatide, same vendor
2 community mentions, no summary yet
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
same lot series
1 community mention, no summary yet
Community Intelligence
- 2 concern reports involving TIR6012062025-09
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other Nexaph Retatrutide batches, not this one.
Also known as: NXP3P240126202613
Activity
No community activity tracked yet.
Vendor
Nexaph